OLIG2 and brain neoplasm: It was further supported by using lipopolymeric nanoparticle-containing combo siRNA (OLIG2, POU3F2, SALL2, and SOX2) targeting brain tumor-initiating cells (BTICs) in a mouse brain tumor model.